Fairness Opinion | Financial Advisor

Duff & Phelps Provided a Fairness Opinion to capiton in Connection with the Single-Asset Secondary Transaction of KD Pharma Group

capiton
/-/media/assets/images/transactions/2020/capiton.jpg

has completed the single-asset secondary transaction of

KD Pharma Group
2020-01-06T05:00:00.0000000

Connect with us

Bob Bartell
Robert A. Bartell, CFA
President, Corporate Finance
Corporate Finance and Restructuring
Chicago
Phone
Jeffrey Schiedemeyer
Jeff Schiedemeyer
Managing Director
Fairness and Solvency Opinions
Chicago
Phone
Andreas Stoecklin
Andreas Stoecklin
Country Head Germany and Head of Corporate Finance, EMEA
Frankfurt
Phone
Philipp Bose is a director at Duff & Phelps.
Philipp Bose
Director
Corporate Finance and Restructuring
Munich
Phone
David Lee
David Lee
Managing Director
Fairness and Solvency Opinions
New York
Phone

capiton initiated a General Partner (GP)-led single-asset secondary transaction to provide its portfolio company, KD Pharma Group, with duration and follow-on capital to finance significant future growth.

Through a competitive bidding process, the transaction gave existing limited partners of capiton IV fund the option to sell their stake in KD Pharma Group or to stay invested in KD Pharma Group via a continuation fund. The transaction also gives new investors the opportunity to invest in a growing portfolio company. Pantheon and Aberdeen Standard Investments participated as principal new investors alongside other renowned institutions.

Duff & Phelps served as the financial advisor to capiton IV fund and provided a fairness opinion in connection with the transaction.

About capiton
capiton is an independent, owner-managed private equity firm that manages a total fund volume of EUR 1.0 billion. The investment portfolio of capiton AG currently comprises 11 medium-sized companies. As an equity partner, capiton supports management buy-outs and growth financing in established medium-sized companies.

About KD Pharma Group
KD Pharma Group is a worldwide leading omega-3 ingredients producer focused on highly purified omega-3 fatty acids for pharmaceutical and nutraceutical products. Since the acquisition by capiton IV fund in 2013, KD Pharma Group has grown from a single-digit revenue business to one of the industry’s largest players.


{1F8452CE-BB02-4541-A705-86D25933687E} {CA601B88-1E91-4803-A6A4-ECC35D220DCC} {22071366-6F45-4C04-8261-CDFA24749510} {A60877A4-2248-456C-B8DE-728B8C4124FC} {612AFC91-99B8-46FE-AEAF-8C0F5DE0126A} {170088C8-830B-4C38-BC1D-E375A677EEDC} {4C5A8982-398E-4460-A547-03A9284CDC27} {69686C52-C3A5-4F48-97D8-5546105882C4} {C6E677F2-B5B4-485D-AA0E-9FBAA922A793} {2DEEE4D2-8278-4C50-B3FF-1563BB257804} {70E25357-B690-49B8-948F-958DAD26DCD4} /en/transactions/fairness-opinions/fairness-opinion-capiton case study

Stay Ahead with Kroll

Corporate Finance and Restructuring

Comprehensive investment banking, corporate finance, restructuring and insolvency services to investors, asset managers, companies and lenders.

Fairness and Solvency Opinions

Duff & Phelps Opinions is a global leader in Fairness Opinions and Special Committee Advisory, ranking #1 for total number of U.S. and global fairness opinions over the past 10 years, according to Refinitiv cumulative data from 2011-2020.

M&A Advisory

Kroll Corporate Finance supports companies and their advisors through every stage of M&A.

Transaction Advisory Services

Kroll’s Transaction Advisory Services is unencumbered by audit independence concerns and offers seamless analytical service throughout the deal continuum.

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Private Capital Markets – Debt Advisory

Kroll has extensive experience raising capital for middle-market companies to support a wide range of transactions.

Tax Services

Built upon the foundation of its renowned valuation business, Kroll's Tax Service practice follows a detailed and responsive approach to capturing value for clients.

Valuation

Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.